BTK and cardiac arrhythmia: Additional risk factors of QT prolongation, such as concomitant use of drugs that increase QT intervals, should be identified, as QT prolongation is one of the most common arrhythmias related to the use of BTK and PI3K inhibitors and nilotinib or bosutinib.